Literature DB >> 3063991

Use of implantable pumps for central nervous system drug infusions to treat neurological disease.

R E Harbaugh1, R L Saunders, R F Reeder.   

Abstract

Increasing knowledge of the neurochemical aspects of central nervous system function raises the possibility of treating neurological disease by the appropriate manipulation of neurotransmitters, neuromodulators, and neurohormones. Clinical application of this knowledge has been inhibited, however, by long-standing problems with drug delivery to the central nervous system (CNS). The availability of implantable drug infusion pumps and stereotactic catheter placement techniques may overcome many of these problems. The problems of drug delivery to the brain and the present and potential uses of implantable drug pumps for neurological disease are discussed. In addition, the relationship between CNS drug infusion and neural tissue transplantation is briefly reviewed.

Entities:  

Mesh:

Year:  1988        PMID: 3063991     DOI: 10.1227/00006123-198812000-00001

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  9 in total

Review 1.  Determinants of passive drug entry into the central nervous system.

Authors:  M D Habgood; D J Begley; N J Abbott
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

2.  Novel drug delivery system using thermoreversible gelation polymer for malignant glioma.

Authors:  Takao Arai; Tatsuhiro Joki; Masaharu Akiyama; Miyuki Agawa; Yuichi Mori; Hiroshi Yoshioka; Toshiaki Abe
Journal:  J Neurooncol       Date:  2006-03       Impact factor: 4.130

Review 3.  Implantable pumps for drug delivery to the brain.

Authors:  S Bakhshi; R B North
Journal:  J Neurooncol       Date:  1995-11       Impact factor: 4.130

4.  Polymeric controlled-release amsacrine chemotherapy in an experimental glioma model.

Authors:  L U Wahlberg; P M Almqvist; M J Glantz; J Boëthius
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

5.  Nerve growth factor expression by PLG-mediated lipofection.

Authors:  Kevin J Whittlesey; Lonnie D Shea
Journal:  Biomaterials       Date:  2005-11-28       Impact factor: 12.479

6.  Diffusion tensor imaging of cocaine-treated rodents.

Authors:  Ponnada A Narayana; Pallavi Ahobila-Vajjula; Jaivijay Ramu; Juan Herrera; Joel L Steinberg; F Gerard Moeller
Journal:  Psychiatry Res       Date:  2009-02-12       Impact factor: 3.222

Review 7.  The expanding role of chemotherapy for pediatric supratentorial malignant gliomas.

Authors:  D C Lyden; W P Mason; J L Finlay
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

8.  Strategies for enhanced drug delivery to the central nervous system.

Authors:  V S N M Dwibhashyam; A N Nagappa
Journal:  Indian J Pharm Sci       Date:  2008 Mar-Apr       Impact factor: 0.975

Review 9.  Current approaches to enhance CNS delivery of drugs across the brain barriers.

Authors:  Cui-Tao Lu; Ying-Zheng Zhao; Ho Lun Wong; Jun Cai; Lei Peng; Xin-Qiao Tian
Journal:  Int J Nanomedicine       Date:  2014-05-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.